EICHOR
● Active Not Recruiting
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
Condition: Chronic Migraine · Sponsor: Ipsen
About this study
The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic migraine. A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head, and is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Chronic migraine is defined as having at least 15 days of headache a month with at least 8 of those days being migraine headache days. Migraines are caused by a series of events which cause the brain to get stimulated/activated, which results in the release of chemicals that cause pain. Dysport® is a formulation of Botulinum toxin type A (BoNT-A), a medication that stops the release of these chemical messengers. The study will consist of 3 periods: 1. A 'screening period' of 6 to 12 weeks to assess whether the participant can take part to the study and requires 1 visit. 2. A first Treatment Phase of 24 weeks. On Day 1 and at Week 12 of the first Treatment Phase, participants will receive injections into various muscles across the head, neck, face and shoulders. The injections will contain either a dose "A" or dose "B" of Dysport® or a placebo (an inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or intervention/treatment being studied). Participants will make 4 visits to the clinic in person and have 4 remote (online) visits. 3. A second Treatment Phase o…
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (120)
| Central Research Associates | Birmingham, Alabama, United States | — |
| CCT Research | Phoenix, Arizona, United States | — |
| HonorHealth Neurology | Scottsdale, Arizona, United States | — |
| Hope Clinical Research, LLC | Canoga Park, California, United States | — |
| Axiom Research LLC | Colton, California, United States | — |
| Fullerton Neurological Center | Fullerton, California, United States | — |
| Neurology Center of North Orange County | Fullerton, California, United States | — |
| The Los Angeles Headache Center | Los Angeles, California, United States | — |
| SDS Clinical Trials | Orange, California, United States | — |
| 840011 | Palo Alto, California, United States | — |
| Stanford University School of Medicine - Stanford Cardiovascular Institute (CVI) | Palo Alto, California, United States | — |
| Alliance Clinical San Diego (Acclaim Clinical Research) | San Diego, California, United States | — |
+ 108 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.